Balyasny Asset Management L.P.

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1218710 Chicago, IL

Position in CLDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$979,106

-$1,717,918 QoQ

Shares Held

26,313

-69.1% QoQ

Ownership

0.034%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#128

of 252 holders

Holding Since

Dec 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. CLDX ranks #128 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$979,106	26,313	-69.1%	Shares	Sole	2026-08-14
2026-03-31	$2,697,024	85,026	+631.0%	Shares	Sole	2026-05-15
2025-09-30	$300,919	11,632	-86.6%	Shares	Sole	2025-11-14
2024-09-30	$2,942,616	86,573	+33.7%	Shares	Sole	2024-11-14
2024-03-31	$2,718,354	64,769	+168.5%	Shares	Sole	2024-05-13
2023-12-31	$956,559	24,119	-12.0%	Shares	Sole	2024-02-14
2023-09-30	$754,460	27,415	-55.2%	Shares	Sole	2023-11-14
2022-03-31	$2,085,834	61,240	+731.8%	Shares	Sole	2022-05-16
2021-12-31	$284,467	7,362	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.